Telephone +44 (0)845 299 3935

Fax +44 (0)1204 441 363

Enquiries enquiries@zerenex-molecular.com

Sales sales@zerenex-molecular.com

Get in touch

Top of page

Industry News

The European Commission has ruled that UCB’s anti-epileptic Vimpat can be used in children.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us